Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[ancestry category]	Characteristics[sex]	Characteristics[disease]	Characteristics[individual]	Material Type	assay name	Technology Type	comment[label]	comment[file uri]	comment[instrument]	comment[fractionation method]	comment[fraction identifier]	comment[separation]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	factor value[organism part]
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	tissue	run 1	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_1.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	tissue	run 2	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_2.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	tissue	run 3	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_3.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	tissue	run 4	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_4.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	tissue	run 5	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_5.raw	prostate tumors tissue
Sample 1	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC5	tissue	run 6	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC5_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC5_6.raw	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	tissue	run 7	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_1.raw	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	tissue	run 8	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_2.raw	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	tissue	run 9	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_3.raw	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	tissue	run 10	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_4.raw	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	tissue	run 11	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_5.raw	prostate tumors tissue
Sample 2	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC6	tissue	run 12	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110715_EXQ2_TaGe_SA_PC6_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110715_EXQ2_TaGe_SA_PC6_6.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	tissue	run 13	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC23_1_110730171023.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC23_1_110730171023.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	tissue	run 14	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_2_110730211136.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_2_110730211136.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	tissue	run 15	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_3.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	tissue	run 16	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_4.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	tissue	run 17	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_5.raw	prostate tumors tissue
Sample 3	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC23	tissue	run 18	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PS23_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PS23_6.raw	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	tissue	run 19	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_1.raw	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	tissue	run 20	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_2.raw	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	tissue	run 21	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_3.raw	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	tissue	run 22	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_4.raw	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	tissue	run 23	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_5.raw	prostate tumors tissue
Sample 4	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC24	tissue	run 24	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC24_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC24_6.raw	prostate tumors tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	tissue	run 25	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_1.raw	non-malignant prostate tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	tissue	run 26	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_2.raw	non-malignant prostate tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	tissue	run 27	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_3.raw	non-malignant prostate tissue
Sample 5	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC25	tissue	run 28	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110729_EXQ3_TaGe_SA_PC25_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110729_EXQ3_TaGe_SA_PC25_4.raw	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	tissue	run 29	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_1.raw	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	tissue	run 30	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_2.raw	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	tissue	run 31	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_3.raw	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	tissue	run 32	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_4.raw	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	tissue	run 33	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_5.raw	non-malignant prostate tissue
Sample 6	Homo sapiens	non-malignant prostate tissue	not available	not available	not applicable	not applicable	not available	not available	control	PC18	tissue	run 34	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC18_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC18_6.raw	non-malignant prostate tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	tissue	run 35	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_1.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	1	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_1.raw	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	tissue	run 36	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_2.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	2	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_2.raw	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	tissue	run 37	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_3.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	3	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_3.raw	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	tissue	run 38	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_4.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	4	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_4.raw	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	tissue	run 39	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_5.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	5	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_5.raw	prostate tumors tissue
Sample 7	Homo sapiens	prostate tumors tissue	not available	not available	not applicable	not applicable	not available	not available	Prostate adenocarcinoma	PC19	tissue	run 40	proteomic profiling by mass spectrometry	SILAC light	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/06/PXD003515/20110819_EXQ3_TaGe_SA_PC19_6.raw	NT=Q Exactive;AC=MS:1001911	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	6	NT=Strong anion-exchange chromatography;AC=PRIDE:0000558	AC=MS:1000422;NT=HCD	not available	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	not available	not available	not available	20110819_EXQ3_TaGe_SA_PC19_6.raw	prostate tumors tissue
